Pluri Inc.
Biotechnology firm with 3D cell-expansion tech for manufacturing cell-based products.
PLUR | TA
Overview
Corporate Details
- ISIN(s):
- US72942G2030
- LEI:
- Country:
- Israel
- Address:
- Park Building No. 5, 3508409 Haifa
- Website:
- https://pluri-biotech.com/
- Sector:
- Manufacturing
Description
Pluri Inc. is a biotechnology company specializing in proprietary 3D cell-expansion technology. The company develops and operates platforms for the scalable, consistent, and cost-effective manufacturing of cell-based products. Its technology is applied across multiple sectors, including regenerative medicine, cell therapy, food technology, and agriculture technology (AgTech). Pluri aims to create next-generation cell-based products to improve human wellbeing and establishes partnerships to leverage its platform. The company also provides Contract Development and Manufacturing Organization (CDMO) services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-04-30 11:00 |
EIB signs collaboration with Israel Innovation Authority and €50 million
finan…
|
English | 448.5 KB | ||
| 2020-04-30 11:00 |
EIB signs collaboration with Israel Innovation Authority and €50 million
finan…
|
English | 37.8 KB | ||
| 2020-04-27 14:59 |
The European Investment Bank (EIB), EU Delegation to Israel,
the Israel Innova…
|
English | 995.9 KB | ||
| 2020-04-27 14:59 |
The European Investment Bank (EIB), EU Delegation to Israel,
the Israel Innova…
|
English | 37.8 KB | ||
| 2020-04-24 16:44 |
PSTI 8K EIB Funding Announecement
|
English | 114.0 KB | ||
| 2020-04-24 16:44 |
PSTI 8K EIB Funding Announecement
|
English | 37.8 KB | ||
| 2020-04-24 15:01 |
Pluristem Secures €50 Million Non-Dilutive Financing from the
European Investm…
|
English | 86.7 KB | ||
| 2020-04-24 15:01 |
Pluristem Secures €50 Million Non-Dilutive Financing from the
European Investm…
|
English | 37.8 KB | ||
| 2020-04-13 18:33 |
8-K -Pluristem Treated First COVID-19 Patient in U.S. Under FDA Single Patient …
|
English | 112.6 KB | ||
| 2020-04-13 18:33 |
8-K -Pluristem Treated First COVID-19 Patient in U.S. Under FDA Single Patient …
|
English | 37.8 KB | ||
| 2020-04-13 15:00 |
Pluristem Expands its Compassionate Use Program:
Treated First COVID-19 Patien…
|
English | 82.5 KB | ||
| 2020-04-13 15:00 |
Pluristem Expands its Compassionate Use Program:
Treated First COVID-19 Patien…
|
English | 37.8 KB | ||
| 2020-04-07 18:28 |
8K: Pluristem Reports Preliminary Data from its COVID-19 Compassionate Use Prog…
|
English | 126.7 KB | ||
| 2020-04-07 18:28 |
8K: Pluristem Reports Preliminary Data from its COVID-19 Compassionate Use Prog…
|
English | 37.8 KB | ||
| 2020-04-07 16:52 |
Reports Preliminary Data from its COVID-19
Compassionate Use Program
„h All…
|
English | 1017.5 KB |
Automate Your Workflow. Get a real-time feed of all Pluri Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pluri Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pluri Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
